Skip to content
Menu

NeoGenomics Raises FY2026 Sales Guidance from $802.000M-$806.000M to $807.000M-$809.000M vs $805.827M Est

Benzinga Newsdesk 3 weeks ago

NewsGuidance

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

NeoGenomics (NASDAQ:NEO) raises FY2026 sales outlook from $802.000 million-$806.000 million to $807.000 million-$809.000 million vs $805.827 million estimate.

NeoGenomics (NASDAQ:NEO) raises FY2026 sales outlook from $802.000 million-$806.000 million to $807.000 million-$809.000 million vs $805.827 million estimate.

Read at benzinga.com